TOWA PHARMACEUTICAL CO. LTD.

  • COMPANY
  • PRODUCTS
  • SUPPLY
  • IR

IR

Balance Sheets(consolidated)

(million yen)

FY2019
(2019/4/1-2020/3/31)		FY2020
(2020/4/1-2021/3/31)
(Assets)
Current assets
Cash and deposits 18,713 22,913
Notes and accounts receivable 35,191 38,122
Electronically recorded monetary claims 6,401 7,694
Finished products 24,659 30,083
Interim products 8,339 8,636
Raw materials and stored goods 18,051 22,232
Currency swaps 5,324 2,935
Other current assets 4,864 4,702
Allowance for doubtful accounts △20 △32
Total current assets 121,525 137,290
Fixed assets
Buildings and structures (net) 18,560 49,093
Machineries, equipments and carriers (net) 13,033 12,628
Land 12,874 13,288
Constructions in progress 4,936 8,769
Other tangible fixed assets (net) 2,224 2,119
Total tangible fixed assets 81,629 85,898
Goodwill 7,622 7,050
Other intangible assets 7,912 7,913
Total Intangible fixed assets 15,534 14,963
Investments
Investment securities 455 519
Stock of subsidiaries and associates 245 1,113
Deferred tax assets 4,880 4,239
Net defined benefit asset 27 34
Others 5,825 1,758
Allowance for doubtful accounts △107 △148
Total investments and other assets 11,327 7,516
Total fixed assets 108,491 108,378
Total assets 230,016 245,668
,

(million yen)

FY2019FY2020
(Liabilities)
Current liabilities
Trade notes and accounts payable 9,585 10,000
Electronically recorded obligations-operating 11,147 13,168
Short-term debt 21,368 1,111
Current portion of long-term debt 6,767 7,181
Accrued expenses 8,807 9,542
Accrued income taxes 4,060 2,527
Accrued bonuses for directors and Auditors 54 100
Notes payable-equipment 2,594 2,375
Accounts payable-equipment 1,106 1,869
Other current liabilities 4,670 3,639
Total current liabilities 70,164 51,516
Long-term liabilities
Convertible bond 15,024 4,153
Long-term debt 36,640 69,945
Net defined benefit liability 364 540
Other long-term liabilities 3,157 2,545
Total long-term liabilities 55,187 77,552
Total liabilities 125,351 129,069
(Net Assets)
Shareholders' equity
Capital stock 4,717 4,717
Capital surplus 7,870 7,834
Retained earnings 97,171 108,629
Treasury stock △5,627 △5,626
Total shareholders' equity 104,132 115,554
Other accumulated comprehensive income
Difference on revaluation of marketable securities 79 124
Foreign currency translation adjustment 453 920
Total other accumulated comprehensive income 532 1,044
Total net assets 104,665 116,599
Total liabilities and net assets 230,016 245,668